Incannex Healthcare Inc. (IXHL) Form 8-K Material Events
Incannex Healthcare Inc. (IXHL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IXHL
CIK: 1873875
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton Audit Pty Ltd
Auditor SinceSince 6/30/2024 12:00:00 AM
Lead Engagement PartnerLorenzo Stella
Audit LocationPerth, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-K | 2026-09-25 | 2026-06-30 | 10-K | 0001628280-26-063506 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | CURRENT REPORT | 0001213900-26-098213 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-25 | CURRENT REPORT | 0001213900-26-093244 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001326389-26-000065 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | CURRENT REPORT | 0001213900-26-087493 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | CURRENT REPORT | 0001213900-26-080622 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-25 | CURRENT REPORT | 0001213900-26-071745 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-10 | CURRENT REPORT | 0001213900-26-067081 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-09 | CURRENT REPORT | 0001213900-26-066526 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057227 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | CURRENT REPORT | 0001213900-26-056227 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | CURRENT REPORT | 0001213900-26-054725 | View SEC Doc Filr Page |
| 8-K | 2026-04-22 | 2026-04-22 | CURRENT REPORT | 0001213900-26-046408 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-27 | CURRENT REPORT | 0001213900-26-035161 | View SEC Doc Filr Page |
| 8-K | 2026-03-25 | 2026-03-25 | CURRENT REPORT | 0001213900-26-033842 | View SEC Doc Filr Page |
| 8-K | 2026-03-18 | 2026-03-18 | CURRENT REPORT | 0001213900-26-029761 | View SEC Doc Filr Page |
| 8-K | 2026-03-17 | 2026-03-16 | CURRENT REPORT | 0001213900-26-028661 | View SEC Doc Filr Page |
| 424B5 | 2026-03-12 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-026966 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-12 | CURRENT REPORT | 0001213900-26-026645 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-11 | CURRENT REPORT | 0001213900-26-026644 | View SEC Doc Filr Page |
| 8-K | 2026-02-25 | 2026-02-24 | CURRENT REPORT | 0001213900-26-020127 | View SEC Doc Filr Page |
| 10-Q | 2026-02-13 | 2025-12-31 | QUARTERLY REPORT | 0001213900-26-015867 | View SEC Doc Filr Page |
| 8-K | 2026-01-29 | 2026-01-29 | CURRENT REPORT | 0001213900-26-009160 | View SEC Doc Filr Page |
| 8-K | 2026-01-22 | 2026-01-22 | CURRENT REPORT | 0001213900-26-006448 | View SEC Doc Filr Page |
| 8-K | 2026-01-16 | 2026-01-15 | CURRENT REPORT | 0001213900-26-004866 | View SEC Doc Filr Page |